Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001532155-25-000107
Filing Date
2025-05-14
Accepted
2025-05-14 17:22:21
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5528
  Complete submission text file 0001532155-25-000107.txt   7339
Mailing Address 501 COMMERCE STREET NASHVILLE TN 37203
Business Address 501 COMMERCE STREET NASHVILLE TN 37203 6156220000
ALLIANCEBERNSTEIN L.P. (Filed by) CIK: 0001109448 (see all company filings)

EIN.: 134064930 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 2901 TASMAN DR. SUITE 205 SANTA CLARA CA 95054
Business Address 2901 TASMAN DR. SUITE 205 SANTA CLARA CA 95054 408-242-7319
Astera Labs, Inc. (Subject) CIK: 0001736297 (see all company filings)

EIN.: 823437062 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94494 | Film No.: 25947171
SIC: 3674 Semiconductors & Related Devices
(CF Office: 04 Manufacturing)